May 23pennslammer38500hs, WuXi AppTec announced that its R & D and production base in Singapore has officially started construction. When the new base is operating at full capacity, there will be 7 R & D and production workshops to provide API R & D and production services for small molecules, oligonucleotides, polypeptides and complex synthetic conjugated drugs. The Singapore base is planned to be put into operation in 2027, and the overall project construction will be advanced in stages. After full completion, the new base is expected to create 1600 jobs.
